Skip to main content

Table 5 Providers´ replies to theoretical clinical situations

From: Use of antenatal corticosteroids for preterm birth in Latin America: providers knowledge, attitudes and practices

 

El Salvador (N=109)

Mexico (N=59)

Ecuador (N=64)

Uruguay (N=121)

 

n/N

(%)

n/N

(%)

n/N

(%)

n/N

(%)

CLI NICAL SITUATION 1

        

Prescribe antenatal corticosteroids to a healthy women in a gestational age of 27 weeks who is hospitalized due to TPL

81/108

(75.0)

24/51

(47.1)

45/61

(73.8)

102/105

(97.1)

The woman is discharged after 72 hs. The TPL is arrested. ¿Which is the indication?

A doses every month

5/105

(4.8)

5/41

(12.2)

0/56

(0.0)

3/105

(2.9)

A doses every two weeks

1/105

(1.0)

1/41

(2.4)

2/56

(3.6)

1/105

(1.0)

A doses every week

24/105

(22.9)

10/41

(24.4)

8/56

(14.3)

8/105

(7.6)

No doses

68/105

(64.8)

0/41

(0.0)

40/56

(71.4)

71/105

(67.6)

Other

7/105

(6.7)

25/41

(61.0)

6/56

(10.7)

22/105

(21.0)

Prescribe antenatal corticosteroids for the same patient if she is hospitalized again due to TPL at the gestational age of 32 weeks

42/107

(39.3)

  

25/60

(41.7)

50/106

(47.2)

CLI NICAL SITUATION 2

        

Prescribe antenatal corticosteroids to a healthy women with a gestational age of 25 weeks who is hospitalized due to a rupture of membranes of 4 hours of evolution, without cervical dilatation and signs of infection

48/108

(44.4)

21/48

(43.8)

27/61

(44.3)

82/105

(78.1)

CLINICAL SITUATION 3

Prescribe antenatal corticosteroids to a healthy woman with two previous preterm births at 30 and 32 weeks and with the actual pregnancy with no complications

82/108

(75.9)

25/47

(53.2)

27/61

(44.3)

71/107

(66.4)